Rheun-Chuan Lee Selected Research

Rheun-Chuan Lee Research Topics

Disease

29	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 01/2008
28	Neoplasms (Cancer) 11/2021 - 04/2005
9	Ascites 11/2021 - 05/2011
7	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2012
7	Liver Neoplasms (Liver Cancer) 11/2021 - 01/2012
5	Adenocarcinoma 01/2022 - 04/2005
4	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 09/2003
4	Rectal Neoplasms (Rectal Cancer) 11/2013 - 03/2005
3	Hepatitis B 04/2022 - 02/2013
3	Neutropenia 02/2022 - 09/2003
3	Thrombosis (Thrombus) 01/2022 - 01/2013
3	Fibrosis (Cirrhosis) 11/2021 - 02/2013
3	End Stage Liver Disease 01/2017 - 11/2009
3	Fever (Fevers) 07/2013 - 08/2008
2	False Aneurysm (Pseudoaneurysm) 01/2022 - 10/2021
2	Hemorrhage 10/2021 - 08/2021
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2017 - 05/2016
2	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 05/2016
2	Thrombocytopenia (Thrombopenia) 09/2013 - 09/2003
2	Cysts 11/2006 - 02/2003
1	Chronic Hepatitis B 04/2022
1	Infections 04/2022
1	Disease Progression 02/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Microsatellite Instability 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Duodenal Ulcer (Curling's Ulcer) 10/2021
1	Sinistral Portal Hypertension 08/2021
1	Varicose Veins (Varicose Vein) 08/2021
1	Hepatitis 04/2021
1	Renal Insufficiency (Renal Failure) 04/2020
1	Brain Neoplasms (Brain Tumor) 04/2019
1	Residual Neoplasm 01/2018
1	Cholangiocarcinoma 09/2017
1	Anemia 09/2013
1	Inflammation (Inflammations) 07/2013
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 06/2013
1	Hepatomegaly 06/2013
1	Jaundice (Icterus) 06/2013
1	Tumor Lysis Syndrome 01/2012
1	Carcinoid Tumor (Carcinoid) 01/2012
1	Necrosis 11/2011
1	Hepatic Encephalopathy 07/2011

Drug/Important Bio-Agent (IBA)

12	AlbuminsIBA 04/2022 - 11/2007
10	BilirubinIBA 04/2022 - 07/2011
10	Fetal Proteins (Fetoprotein)IBA 11/2021 - 05/2011
6	Yttrium-90IBA 04/2021 - 11/2011
5	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 01/2008
5	Sorafenib (BAY 43-9006)FDA Link 02/2022 - 03/2015
5	SirtuinsIBA 01/2018 - 01/2012
4	Gemcitabine FDA Link 02/2022 - 09/2003
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
4	Cytidine Triphosphate (CTP)IBA 11/2021 - 12/2011
4	Leucovorin (Folinic Acid)FDA Link 02/2010 - 03/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 01/2008
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2020 - 11/2015
2	Ethiodized Oil (Ethiodol)FDA Link 10/2021 - 08/2021
2	CytokinesIBA 04/2021 - 07/2013
2	CreatinineIBA 02/2021 - 06/2010
2	Serum AlbuminIBA 03/2016 - 12/2014
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2015 - 12/2014
2	UracilIBA 02/2010 - 03/2005
2	TegafurIBA 02/2010 - 03/2005
2	Etoposide (VP 16)FDA LinkGeneric 11/2009 - 01/2008
2	Fluorouracil (Carac)FDA LinkGeneric 01/2008 - 09/2003
2	MucinsIBA 11/2006 - 02/2003
1	YttriumIBA 06/2022
1	Hydralazine (Apresoline)FDA LinkGeneric 02/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 02/2022
1	Dacarbazine (DIC)FDA LinkGeneric 02/2022
1	LigandsIBA 01/2022
1	lenvatinibIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	NivolumabIBA 01/2022
1	Axitinib (AG 013736)IBA 01/2020
1	Alkaline PhosphataseIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 07/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2013
1	trisacryl gelatin microspheresIBA 01/2012

Therapy/Procedure

11	Radiotherapy 06/2022 - 03/2005
7	Therapeutics 02/2022 - 01/2012
6	Microspheres (Microsphere) 06/2022 - 11/2011
6	Drug Therapy (Chemotherapy) 02/2022 - 01/2008
6	Chemoradiotherapy 12/2010 - 09/2003
3	Surgical Instruments (Clip) 04/2021 - 03/2013
2	Pancreaticoduodenectomy 10/2021 - 08/2021
2	Conservative Treatment 10/2021 - 07/2009
2	Retreatment 02/2020 - 11/2015
2	Neoadjuvant Therapy 11/2013 - 04/2005
2	Liver Transplantation 10/2010 - 11/2009
1	Immunotherapy 01/2022
1	Punctures 01/2022
1	Stents 10/2021
1	Contraindications 08/2021
1	Salvage Therapy 01/2020
1	Boron Neutron Capture Therapy 04/2019
1	Transplantation 09/2017
1	Cholecystectomy 01/2017
1	Pancreas Transplantation 06/2013